Search

Search Constraints

You searched for: Author/Creator Watanabe, Yasutaka

Search Results

2. A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy. (March 2023)

3. Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010). Issue 12 (21st September 2022)

7. Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects. Issue 6 (6th May 2016)

8. Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE. Issue 2 (10th January 2022)